Mutual independence of 5-HT 2 and α1 noradrenergic receptors in mediating deficits in sensorimotor gating

Psychopharmacology

Volumn 220, Issue 3, 2012, Pages 465-479

  Baisley, Sarah K ^a,b   Fallace, Katherine L ^a   Rajbhandari, Abha K ^a,b   Bakshi, Vaishali P ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Locomotion; Noradrenergic; Schizophrenia; Serotonergic; Startle; Stereotypy

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; ALPHA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CIRAZOLINE; PRAZOSIN; RITANSERIN; SEROTONIN 2 RECEPTOR; TIMOLOL;

ADRENERGIC ACTIVITY; ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; LOCOMOTION; MALE; NEUROMODULATION; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; RAT; SENSORIMOTOR FUNCTION; SENSORY GATING; SENSORY STIMULATION; SEROTONINERGIC TRANSMISSION; STARTLE REFLEX;

ADRENERGIC ALPHA-1 RECEPTOR AGONISTS; ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, SEROTONIN, 5-HT2; SCHIZOPHRENIA; SENSORY GATING; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS; STARTLE REACTION;

EID: 84858446573     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2490-2     Document Type: Article

References (95)

1. Aghajanian GK (1980) Mescaline and LSD facilitate the activation of locus coeruleus neurons by peripheral stimuli. Brain Res 186:492-498 (Pubitemid 10143821)
2. Aloyo VJ, Walker RF (1988) Alpha-adrenergic control of serotonin release from rat pineal glands. Neuroendocrinology 48:61-66
3. Alsene KM, Carasso BS, Connors EE, Bakshi VP (2006) Disruption of prepulse inhibition after stimulation of central but not peripheral alpha-1 adrenergic receptors. Neuropsychopharmacol-ogy 31:2150-2161 (Pubitemid 44413192)
4. Alsene KM, Fallace K, Bakshi VP (2010) Ventral striatal noradren-ergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine. Neuropsychopharmacology 35:2346-2356
5. Alsene KM, Rajbhandari AK, Ramaker MJ, Bakshi VP (2011) Discrete forebrain neuronal networks supporting noradrenergic regulation of sensorimotor gating. Neuropsychopharmacology 36:1003-1014
6. Amargos-Bosch M, Adell A, Bortolozzi A, Artigas F (2003) Stimulation of alpha1-adrenoceptors in the rat medial prefrontal cortex increases the local in vivo 5-hydroxytryptamine release: reversal by antipsychotic drugs. J Neurochem 87:831-842 (Pubitemid 37444559)
7. Andrade R, Barnes NM, Baxter G, Bockaert J, Branchek T, Cohen ML, Dumuis A, Eglen RM, Gothert M, Hamblin M, Hamon M, Hartig PR, Hen R, Herrick-Davis K, Hills R, Hoyer D, Humphrey PPA, Latté KP, Maroteaux L, Martin GR, Middlemiss DN, Mylecharane E, Peroutka SJ, Saxena PR, Sleight A, Villalon CM, Yocca F (2010) 5-Hydroxytryptamine receptors, introductory chapter., pp IUPHAR database (IUPHAR-DB)
8. Auclair A, Drouin C, Cotecchia S, Glowinski J, Tassin JP (2004) 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants. Eur J Neurosci 20:3073-3084 (Pubitemid 40007302)
9. Baraban JM, Aghajanian GK (1980) Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19:355-363 (Pubitemid 10095684)
10. Berendsen HH, Kester RC, Peeters BW, Broekkamp CL (1996) Modulation of 5-HT receptor subtype-mediated behaviours by corticosterone. Eur J Pharmacol 308:103-111 (Pubitemid 26237035)
11. Blier P (2001) Crosstalk between the norepinephrine and serotonin systems and its role in the antidepressant response. J Psychiatry Neurosci 26(Suppl):S3-S10 (Pubitemid 34218788)
12. Blier P, Briley M (2011) The noradrenergic symptom cluster: clinical expression and neuropharmacology. Neuropsychiatr Dis Treat 7:15-20
13. Braff DL (2010) Prepulse inhibition of the startle reflex: a window on the brain in schizophrenia. Curr Top Behav Neurosci 4:349-371
14. Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156:234-258 (Pubitemid 32705488)
15. Braff DL, Greenwood TA, Swerdlow NR, Light GA, Schork NJ (2008) Advances in endophenotyping schizophrenia. World Psychiatry 7:11-18 (Pubitemid 351338180)
16. Brea J, Castro M, Loza MI, Masaguer CF, Ravina E, Dezi C, Pastor M, Sanz F, Cabrero-Castel A, Galan-Rodriguez B, Fernandez-Espejo E, Maldonado R, Robledo P (2006) QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine. Neuropharmacology 51:251-262 (Pubitemid 44061887)
17. Briody S, Boules M, Oliveros A, Fauq I, Richelson E (2010) Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance. Behav Brain Res 207:118-124
18. Bylund DB, Bond RA, Eikenburg DC, Hieble JP, Hills R, Minneman KP, Parra S (2009) Adrenoceptors, introductory chapter
19. Carasso BS, Bakshi VP, Geyer MA (1998) Disruption in prepulse inhibition after alpha-1 adrenoceptor stimulation in rats. Neuro-pharmacology 37:401-404 (Pubitemid 28282646)
20. Castagne V, Moser PC, Porsolt RD (2009) Preclinical behavioral models for predicting antipsychotic activity. Adv Pharmacol 57:381-418
21. Chaouloff F, Baudrie V, Coupry I (1994) Effects of chlorisondamine and restraint on cortical [3H]ketanserin binding, 5-HT2A receptor-mediated head shakes, and behaviours in models of anxiety. Neuropharmacology 33:449-456
22. Cryan JF, O'Leary OF, Jin SH, Friedland JC, Ouyang M, Hirsch BR, Page ME, Dalvi A, Thomas SA, Lucki I (2004) Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proc Natl Acad Sci USA 101:8186-8191 (Pubitemid 38698075)
23. Darmani NA, Martin BR, Pandey U, Glennon RA (1991) Inhibition of 5-HT2 receptor-mediated head-twitch response by cocaine via indirect stimulation of adrenergic alpha 2 and serotonergic 5-HT1A receptors. Pharmacol Biochem Behav 38:353-357
24. Davis M, Gendelman DS, Tischler MD, Gendelman PM (1982) A primary acoustic startle circuit: lesion and stimulation studies. J Neurosci 2:791-805 (Pubitemid 12064613)
25. Done CJ, Sharp T (1992) Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo. Br J Pharmacol 107:240-245
26. Dursun SM, Handley SL (1996) Similarities in the pharmacology of spontaneous and DOI-induced head-shakes suggest 5HT2A receptors are active under physiological conditions. Psychophar-macology (Berl) 128:198-205 (Pubitemid 26383307)
27. Ellenbroek BA (2004) Pre-attentive processing and schizophrenia: animal studies. Psychopharmacology (Berl) 174:65-74 (Pubitemid 38925092)
28. Farid M, Martinez ZA, Geyer MA, Swerdlow NR (2000) Regulation of sensorimotor gating of the startle reflex by serotonin 2A receptors. Ontogeny and strain differences. Neuropsychopharma-cology 23:623-632
29. Feifel D, Melendez G, Shilling PD (2003) A systemically administered neurotensin agonist blocks disruption of prepulse inhibition produced by a serotonin-2A agonist. Neuropsychopharmacology 28:651-653
30. Fendt M, Li L, Yeomans JS (2001) Brain stem circuits mediating prepulse inhibition of the startle reflex. Psychopharmacology (Berl) 156:216-224 (Pubitemid 32702214)
31. Fone KC, Bennett GW, Marsden CA (1987) Involvement of catecholaminergic neurones and alpha-adrenoceptors in the wet-dog shake and forepaw licking behaviour produced by the intrathecal injection of an analogue of thyrotrophin-releasing hormone (CG 3509). Neuropharmacology 26:1147-1155 (Pubitemid 17136969)
32. Fowler SC, Pinkston JW, Vorontsova E (2007) Clozapine and prazosin slow the rhythm of head movements during focused stereotypy induced by d-amphetamine in rats. Psychopharmacology (Berl) 192:219-230 (Pubitemid 46669206)
33. Geyer MA (1996) Serotonergic functions in arousal and motor activity. Behav Brain Res 73:31-35 (Pubitemid 26008759)
34. Geyer MA (2008) Developing translational animal models for symptoms of schizophrenia or bipolar mania. Neurotox Res 14:71-78
35. Geyer MA, Swerdlow NR, Mansbach RS, Braff DL (1990) Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull 25:485-498 (Pubitemid 20346586)
36. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 156:117-154 (Pubitemid 32702206)
37. Gobbi G, Cassano T, Radja F, Morgese MG, Cuomo V, Santarelli L, Hen R, Blier P (2007) Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function. Eur Neuropsycho-pharmacol 17:328-338
38. Gresack JE, Risbrough VB (2010) Corticotropin-releasing factor and noradrenergic signalling exert reciprocal control over startle reactivity. Int J Neuropsychopharmacol: 1-16
39. Haddjeri N, Blier P, de Montigny C (1995) Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine. Int Clin Psychopharmacol 10(Suppl 4):11-17 (Pubitemid 26058316)
40. Haddjeri N, de Montigny C, Blier P (1997) Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system. Br J Pharmacol 120:865-875 (Pubitemid 27122727)
41. Harkin A, Morris K, Kelly JP, O'Donnell JM, Leonard BE (2001) Modulation of MK-801-induced behaviour by noradrenergic agents in mice. Psychopharmacology (Berl) 154:177-188 (Pubitemid 32186503)
42. Heal DJ, Philpot J, O'Shaughnessy KM, Davies CL (1986) The influence of central noradrenergic function on 5-HT2-mediated head-twitch responses in mice: possible implications for the actions of antidepressant drugs. Psychopharmacology (Berl) 89:414-420 (Pubitemid 16060655)
43. Hillegaart V, Estival A, Ahlenius S (1996) Evidence for specific involvement of 5-HT1A and 5-HT2A/C receptors in the expression of patterns of spontaneous motor activity of the rat. Eur J Pharmacol 295:155-161
44. Hoffman HS, Ison JR (1980) Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input. Psychol Rev 87:175-189
45. Hoyer D, Martin GR (1996) Classification and nomenclature of 5-HT receptors: a comment on current issues. Behav Brain Res 73:263-268 (Pubitemid 26008793)
46. Imai H, Steindler DA, Kitai ST (1986) The organization of divergent axonal projections from the midbrain raphe nuclei in the rat. J Comp Neurol 243:363-380 (Pubitemid 16179241)
47. Ison JR, Hoffman HS (1983) Reflex modification in the domain of startle: II. The anomalous history of a robust and ubiquitous phenomenon. Psychol Bull 94:3-17
48. Kim MA, Lee HS, Lee BY, Waterhouse BD (2004) Reciprocal connections between subdivisions of the dorsal raphe and the nuclear core of the locus coeruleus in the rat. Brain Res 1026:56-67 (Pubitemid 39336416)
49. Kohnomi S, Suemaru K, Kawasaki H, Araki H (2008) Effect of aripiprazole on 5-HT2 receptor-mediated wet-dog shake responses and disruption of prepulse inhibition in rats. J Pharmacol Sci 106:645-650 (Pubitemid 351556244)
50. Kouhata S, Kagaya A, Nakae S, Nakata Y, Yamawaki S (2001) Effect of acute lipopolysaccharide administration on (+/-)-1-(2,5-dime-thoxy-4-iodophenyl)-2 aminopropane-induced wet dog shake behavior in rats: comparison with body weight change and locomotor activity. Prog Neuropsychopharmacol Biol Psychiatry 25:395-407 (Pubitemid 32234658)
51. Krebs-Thomson K, Paulus MP, Geyer MA (1998) Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors. Neuro-psychopharmacology 18:339-351 (Pubitemid 28140659)
52. Kugaya A, Kagaya A, Uchitomi Y, Yokota N, Yamawaki S (1996) Effect of interferon-alpha on DOI-induced wet-dog shakes in rats. J Neural Transm 103:947-955 (Pubitemid 26383830)
53. Kumari V, Soni W, Sharma T (1999) Normalization of information processing deficits in schizophrenia with clozapine. Am J Psychiatry 156:1046-1051 (Pubitemid 29302798)
54. Kumari V, Soni W, Sharma T (2002) Prepulse inhibition of the startle response in risperidone-treated patients: comparison with typical antipsychotics. Schizophr Res 55:139-146 (Pubitemid 34310546)
55. Kumari V, Antonova E, Geyer MA, Ffytche D, Williams SC, Sharma T (2007) A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsy-chotics. Int J Neuropsychopharmacol 10:463-477 (Pubitemid 46985255)
56. Leumann L, Feldon J, Vollenweider FX, Ludewig K (2002) Effects of typical and atypical antipsychotics on prepulse inhibition and latent inhibition in chronic schizophrenia. Biol Psychiatry 52:729-739
57. Ma J, Ye N, Cohen BM (2006) Expression of noradrenergic alpha1, serotoninergic 5HT2a and dopaminergic D2 receptors on neurons activated by typical and atypical antipsychotic drugs. Prog Neuropsychopharmacol Biol Psychiatry 30:647-657
58. Maier W, Mossner R, Quednow BB, Wagner M, Hurlemann R (2008) From genes to psychoses and back: the role of the 5HT2alpha-receptor and prepulse inhibition in schizophrenia. Eur Arch Psychiatry Clin Neurosci 258(Suppl 5):40-43
59. Marek GJ (2009) Activation of adenosine(1) (A(1)) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats. Neuropharmacology 56:1082-1087
60. Millan MJ, Schreiber R, Dekeyne A, Rivet JM, Bervoets K, Mavridis M, Sebban C, Maurel-Remy S, Newman-Tancredi A, Spedding M, Muller O, Lavielle G, Brocco M (1998) S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine and haloperidol. J Pharmacol Exp Ther 286:1356-1373 (Pubitemid 29135550)
61. Mittman SM, Geyer MA (1991) Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol. Psychopharmacology (Berl) 105:69-76
62. O'Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, Lucki I (2007a) Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology (Berl) 192:357-371 (Pubitemid 46701581)
63. O'Leary OF, Bechtholt AJ, Crowley JJ, Valentino RJ, Lucki I (2007b) The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs. Eur Neuropsychopharmacol 17:215-226 (Pubitemid 44779196)
64. Peyron C, Luppi PH, Fort P, Rampon C, Jouvet M (1996) Lower brainstem catecholamine afferents to the rat dorsal raphe nucleus. J Comp Neurol 364:402-413 (Pubitemid 26039427)
65. Pranzatelli MR (1990) Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4- iodophenyl aminopropane)-2 (DOI). Neurosci Lett 115:74-80 (Pubitemid 20231595)
66. Pupo AS, Minneman KP (2001) Adrenergic pharmacology: focus on the central nervous system. CNS Spectr 6:656-662 (Pubitemid 34546963)
67. Rasmussen K, Aghajanian GK (1986) Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2 antagonists. Brain Res 385:395-400 (Pubitemid 16006858)
68. Sallinen J, Höglund I, Engström M, Lehtimäki J, Virtanen R, Sirviö J, Wurster S, Savola JM, Haapalinna A (2007) Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302. Br J Pharmacol 150:391-402 (Pubitemid 46280650)
69. Salomon L, Lanteri C, Glowinski J, Tassin JP (2006) Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons. Proc Natl Acad Sci USA 103:7476-7481 (Pubitemid 43727858)
70. Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ (1995) (1-(2,5-Dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. J Pharmacol Exp Ther 273:101-112
71. Segal M (1979) Serotonergic innervation of the locus coeruleus from the dorsal raphe and its action on responses to noxious stimuli. J Physiol 286:401-415 (Pubitemid 9085493)
72. Shilling PD, Feifel D (2002) SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI. Psychopharmacology (Berl) 164:285-293 (Pubitemid 35340995)
73. Shilling PD, Melendez G, Priebe K, Richelson E, Feifel D (2004) Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an alpha1 agonist. Psychopharma-cology (Berl) 175:353-359 (Pubitemid 39361923)
74. Sim LJ, Joseph SA (1993) Dorsal raphe nucleus efferents: termination in peptidergic fields. Peptides 14:75-83
75. Sipes TA, Geyer MA (1994) Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology 33:441-448 (Pubitemid 24168715)
76. Sipes TE, Geyer MA (1995) DOI disruption of prepulse inhibition of startle in the rat is mediated by 5-HT(2A) and not by 5-HT(2C) receptors. Behav Pharmacol 6:839-842
77. Sipes TE, Geyer MA (1997) DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum. Brain Res 761:97-104 (Pubitemid 27314738)
78. Starke K (2001) Presynaptic autoreceptors in the third decade: focus on alpha2-adrenoceptors. J Neurochem 78:685-693 (Pubitemid 32777970)
79. Stone EA, Lin Y, Ahsan R, Quartermain D (2004) Gross mapping of alpha1-adrenoceptors that regulate behavioral activation in the mouse brain. Behav Brain Res 152:167-175 (Pubitemid 38757887)
80. Stone EA, Lin Y, Sarfraz Y, Quartermain D (2009) Marked behavioral activation from inhibitory stimulation of locus coeruleus alpha1-adrenoceptors by a full agonist. Brain Res 1291:21-31
81. Stone EA, Lin Y, Sarfraz Y, Quartermain D (2011) The role of the central noradrenergic system in behavioral inhibition. Brain Res Rev 67:193-208
82. Swerdlow NR, Geyer MA, Braff DL (2001) Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) 156:194-215 (Pubitemid 32702213)
83. Swerdlow NR, Bongiovanni MJ, Tochen L, Shoemaker JM (2006a) Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette Syndrome. Psychopharmacology (Berl) 186:246-254 (Pubitemid 43727342)
84. Swerdlow NR, Geyer MA, Shoemaker JM, Light GA, Braff DL, Stevens KE, Sharp R, Breier M, Neary A, Auerbach PP (2006b) Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats. Neuropsychopharmacology 31:506-515 (Pubitemid 43276966)
85. Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL (2008) Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl) 199:331-388
86. Szabo ST, Blier P (2001) Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons. Brain Res 922:9-20 (Pubitemid 33152840)
87. van den Buuse M (2010) Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr Bull 36:246-270
88. Vandermaelen CP, Aghajanian GK (1983) Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res 289:109-119 (Pubitemid 14222511)
89. Vanderschuren LJ, Beemster P, Schoffelmeer AN (2003) On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization. Psychopharmacology (Berl) 169:176-185 (Pubitemid 37129969)
90. Varty GB, Higgins GA (1995) Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs. Psychopharmacology (Berl) 122:15-26
91. Varty GB, Bakshi VP, Geyer MA (1999) M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague- Dawley and Wistar rats. Neuropsychopharmacology 20:311-321 (Pubitemid 29099762)
92. Wadenberg MG, Sills TL, Fletcher PJ, Kapur S (2000) Antipsychotic-like effects of amoxapine, without catalepsy, using the prepulse inhibition of the acoustic startle reflex test in rats. Biol Psychiatry 47:670-676 (Pubitemid 30169262)
93. Weidenfeld J, Feldman S, Itzik A, Van de Kar LD, Newman ME (2002) Evidence for a mutual interaction between noradrenergic and serotonergic agonists in stimulation of ACTH and cortico-sterone secretion in the rat. Brain Res 941:113-117 (Pubitemid 34603289)
94. Weiss IC, Feldon J (2001) Environmental animal models for sensorimotor gating deficiencies in schizophrenia: a review. Psychopharmacology (Berl) 156:305-326 (Pubitemid 32702221)
95. Wing LL, Tapson GS, Geyer MA (1990) 5HT-2 mediation of acute behavioral effects of hallucinogens in rats. Psychopharmacology (Berl) 100:417-425 (Pubitemid 20052435)